Welcome to Indian Pharma Observer

You don't need anything else!
 Network With Fellow Professionals
(Complete your own profile for better results)
vikey;   RxProfessionsCROacademy;   relychem;   smkallakuru;   anil;   saakittu;   Shibi;   kavalk;   ravi;   sandeep;   deeps;   HTBS;   Krish;   chitramohan;   Kimi;   lovey;   hemalata;   gauravpandey;   prasanna;   shahima;   isha;   nbs_2281;   sweet;   Amal;   vamsee;   chemist;   ishu;   aashi;   mohanraj;   desienplas;   sheetalmohidekar;   Nasa;   Anahita;   ari;   DD;   praddy;   PPRAO;   abhaykenjale;   Rushang;   dvaidya;   jeetsharma;   tamaravery409;   ArunKumbhat;   karlabaudains427;   Ajit;   aneesh28;   munish;   Martin;   anbarasan;   Rushi;  Search MORE Users
Nickname:
Password:
              
Or, you can register.You get 100 points when you register and activate your account. You can earn points as you use the website and even redeem your points. Check more here
.
  Search News





  News Categories
Pls click on tab to freeze pane

  SPIC urges inspection of API facilities in China mandatory before import - Saturday, July 05, 2008

SME Pharma Industries Confederation (SPIC) has urged the chemicals ministry to make inspection of facilities mandatory before issuing permissions to import APIs from China, which accounts for around 70 per cent of API requirement in the country, to ensure quality of products.

MORE TEXT | COMMENTS | Top Stories
  Open house moots setting up of core group to redress grievances regularly - Saturday, July 05, 2008

The open house meet between the industry and the officials, organised by Pharmaceutical Export Promotion Council (Pharmexcil) on July 3 in New Delhi, suggested setting up of a core group involving different ministries concerned with the pharmaceutical industry and associations to streamline the sector and redress the grievances regularly.

MORE TEXT | COMMENTS | Govt/Policy/Legal
  IDMA to submit detailed cost data on APIs, packaging materials to NPPA soon - Saturday, July 05, 2008

The Indian Drug Manufacturers Association (IDMA) will soon submit latest data on the increase in active pharmaceutical ingredients (APIs) and packaging materials in the past few months to the Ministry of Chemicals and Petrochemicals and the National Pharmaceutical Pricing Authority (NPPA) in a bid to seek necessary price hikes of pharmaceutical products.

MORE TEXT | COMMENTS | Top Stories
  International conference on pharmacovigilance planned on Nov 2 in Mumbai - Friday, July 04, 2008

Symogen and Cognizant Life Sciences are organising an international conference on the topic, first of its kind in the country, from November 2 to 5 in Mumbai to impart information on the good pharmacovigilance practices around the world.

MORE TEXT | COMMENTS | Events
  Pfizer posts net profit of Rs 37.92 crore in Q2 - Friday, July 04, 2008

Pfizer, a leading MNC in India, has achieved net profit of Rs 37.92 crore during the second quarter ended May 2008 as against Rs 257.76 crore in the corresponding period of last year.


MORE TEXT | COMMENTS | Business/Finance
  Dr Saranjit Singh takes over as NIPER dean - Friday, July 04, 2008

Dr Saranjit Singh, professor and head of the Department of Pharmaceutical Analysis, has been appointed as the dean of National Institute of Pharmaceutical Education and Research (NIPER), Mohali.

MORE TEXT | COMMENTS | People / HR
  Cipla gets patent for Nexium, Fosamax modified versions - Thursday, July 03, 2008

Domestic pharma major Cipla has received product patents for new forms of two blockbuster drugs—Osemaprazole and Alendronate—from the Indian authorities.

MORE TEXT | COMMENTS | Awards/ Recognition
  NPC to submit report on PTUF scheme to chemicals ministry soon - Thursday, July 03, 2008

The National Productivity Council (NPC), which was entrusted with the task of working out some viable modalities to disburse the so-far-unutilized Rs 600 crore Pharmaceutical Technology Upgradation Fund (PTUF), will submit its final report to the chemicals ministry soon.

MORE TEXT | COMMENTS | Govt/Policy/Legal
  China to suspend exports of all pharma chemicals for 2 months from mid July - Thursday, July 03, 2008

The Chinese government is likely to suspend the export of all the hazardous substances including pharmaceutical chemicals for the two months starting from mid July to mid September, in connection with Olympics 2008.

MORE TEXT | COMMENTS | Top Stories
  Sun Pharma kicks off open offer to acquire Taro - Wednesday, July 02, 2008

With the one-upmanship game between Sun Pharm and Taro showing no signs of let-up, the Mumbai-based company on Monday commenced an open offer to acquire the Israeli firm completely.


MORE TEXT | COMMENTS | Business/Finance
  Ranbaxy units face FDA heat after inspections - Wednesday, July 02, 2008

Two manufacturing facilities of Ranbaxy Laboratories are learnt to have come under the scanner of the US Food and Drug Administration (USFDA), the drug regulatory body in the US.


MORE TEXT | COMMENTS | Govt/Policy/Legal
  Linking patent status with marketing approval may not harm industry - Wednesday, July 02, 2008

Over 95 per cent of the drugs being produced in India are off-patent and will not be affected by the product patent regime.

MORE TEXT | COMMENTS | Recommended Reading
Pls click on tab to freeze pane


Formulation/Molecule News

Ranbaxy to start clinical trials of anti-inflammatory molecule soon - Economic Times
The vanishing point - Times of India
Thermo Fisher Scientific and Evonik Industries Cooperate to ... - PharmiWeb.com (press release)
Patient shortage hits clinical trials in India - Sify
Generic Copaxone deal boosts Mylan, sinks Teva - CNNMoney.com
Subir Roy: In search of a business model - Business Standard
Pharma pops brand-extension pill - Economic Times
In the global net - Frontline
A small pill on pharma - Times of India
Now, Ranbaxy seeks peace with Takeda - Business Standard

Equipment/Technology News

`There is no emerging trend in Ranbaxy`s move` - Business Standard
Pharma majors tying up with colleges to cut R&D expenses - Economic Times
Sun Pharma, Jet, ICICI Bank, JSW Steel: India Equity Preview - Bloomberg
Drug-resistant TB to be diagnosed in just 2 days - Times of India
Thermo Fisher Scientific and Evonik Industries Cooperate to ... - PharmiWeb.com (press release)
Nigerian sickle-cell drug mired in controversy - Mail & Guardian Online
The world is changing with RFID - Hindu
New Drug-Resistance Test Gives Hope To TB Fight - World Bank Group
Pharmaceutical drug abuse increasing in India: UN0 - Economic Times
Aethlon Medical Announces Second HIV/AIDS Treatment Site - FOXBusiness

Patent/IPR News

Patent-obsessed big pharma joining hands with generics competitors - Economic Times
AstraZeneca sees off generic rival - Financial Times
US, Indian HIV/AIDS Drug Rulings Could Reverberate In Brazil - Intellectual Property Watch
Cipla, AIDS groups oppose Roche`s AIDS drug patent in India - Business Standard
Brazil NGO opposes Gilead`s AIDS drug patent - Business Standard
India rejects Boehringer's AIDS drug patent plea - Times of India
Brazilian organization files opposition to Gilead's antiretroviral ... - News-Medical.net
Indian Generic Drug Companies, HIV/AIDS Advocacy Group File ... - Medical News Today (press release)
UPDATE 1-Ranbaxy, Pfizer settle Lipitor patent disputes - Reuters
Implications Of The Emerging Patent Litigation In India - Mondaq News Alerts (subscription)

  Individual Awards
Nominate* yourself or your friend or your favourite industry icon and vote for them. Last date of voting: December 31, 2008
Pharma Professional Of The Year - 2008

Tapan Ray, DG, OPPI
Venkat Jasti, Chairman, Pharmexcil
Dr Villoo Morawala-Patell, Chairman, Avesthagen
Janak Singh Bajwa, MD, Quest Diagnostics India



Results
Polls

Votes: 6
Comments: 0
(*T&C: Nominations should be sent via email to publisher@chronosphere.biz and each submission should have at least 5 reasons supporting the nomination. The decision on whether to add or delete any particular nomination at any given time rests solely with the website admin. At any given point of time, only 12 nominations will be accepted).

  Newsletters/Communities




_______________________________________________________________________________________________________________

This website is part of Indian Business Observer network, brought to you by Chronosphere. This website is best viewed in 1024 x 768 resolution. Cookies need to be enabled.

For any communication with us, please use the Feedback Module.
Usage of this website is limited by the terms and conditions of usage, as defined in the About-Terms-Privacy module.
_______________________________________________________________________________________________________________
All logos and trademarks on this website are property of their respective owners. The comments are property of their posters. © 2007 Chronosphere.
_______________________________________________________________________________________________________________
Powered by PHP-Nuke